Biotech - Spark Newswire

1 minute read

Emergent BioSolutions Saus Two Batches Of COVID-19 Vaccine Manufactured By Co. Were Determined Suitable For Use By FDA

Today, 3:38 AM

Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batches of COVID-19 vaccine manufactured by Emergent BioSolutions at its Baltimore Bayview facility were determined to be suitable for use by the U.S.

EBS

2 minute read

FDA
News

Quidel Receives Amended Emergency Use Authorization For New Sofia Q Rapid Antigen Test Device

By Benzinga Newsdesk

Today, 3:38 AM

Sofia® Q device features a miniaturized, AI-powered design Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets SAN

QDEL

4 minute read

FDA
News

Novavax Highlights Data From 3 Complementary Studies Of COVID-19 Beta Variant Strain Vaccine

By Benzinga Newsdesk

Today, 3:38 AM

- Recombinant spike protein antigen (rS-B.1.351) based on the Beta (B.1.351) virus lineage highly immunogenic in mice and produced neutralizing antibodies - Primates boosted with rS-B.1.351 induced strong neutralizing

NVAX

1 minute read

FDA
News

Enlivex Earlier National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.’s ‘Phase 2b…Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19…’

By Benzinga Newsdesk

Today, 3:38 AM

https://clinicaltrials.gov/ct2/show/NCT04922957

ENLV

1 minute read

Moderna Says No Link Between COVID-19 Jab And Heart Inflammation

By Vandana Singh

Today, 3:38 AM

Moderna Inc (NASDAQ:MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based…

BNTX

1 minute read

Zynerba’s Zygel Improves Sleep In Children With Severe Epilepsies

By Vandana Singh

Today, 3:38 AM

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) presents sleep data from an open-label Phase 2 trial evaluating Zygel for developmental & epileptic encephalopathies (DEE)…

ZYNE